This company has been marked as potentially delisted and may not be actively trading. Leisure Acquisition (LACQ) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock LACQ vs. RENB, FBIO, VRCA, PEPG, CUE, ATNM, BDRX, ONCY, IMRX, and STTKShould you be buying Leisure Acquisition stock or one of its competitors? The main competitors of Leisure Acquisition include Renovaro (RENB), Fortress Biotech (FBIO), Verrica Pharmaceuticals (VRCA), PepGen (PEPG), Cue Biopharma (CUE), Actinium Pharmaceuticals (ATNM), Biodexa Pharmaceuticals (BDRX), Oncolytics Biotech (ONCY), Immuneering (IMRX), and Shattuck Labs (STTK). Leisure Acquisition vs. Renovaro Fortress Biotech Verrica Pharmaceuticals PepGen Cue Biopharma Actinium Pharmaceuticals Biodexa Pharmaceuticals Oncolytics Biotech Immuneering Shattuck Labs Renovaro (NASDAQ:RENB) and Leisure Acquisition (NASDAQ:LACQ) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, community ranking, media sentiment, analyst recommendations, institutional ownership, dividends, valuation and profitability. Do institutionals and insiders believe in RENB or LACQ? 71.4% of Renovaro shares are held by institutional investors. Comparatively, 56.7% of Leisure Acquisition shares are held by institutional investors. 21.7% of Renovaro shares are held by company insiders. Comparatively, 39.6% of Leisure Acquisition shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the MarketBeat Community favor RENB or LACQ? Renovaro and Leisure Acquisition both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRenovaroN/AN/ALeisure AcquisitionN/AN/A Does the media refer more to RENB or LACQ? In the previous week, Renovaro had 4 more articles in the media than Leisure Acquisition. MarketBeat recorded 4 mentions for Renovaro and 0 mentions for Leisure Acquisition. Renovaro's average media sentiment score of -0.21 beat Leisure Acquisition's score of -1.38 indicating that Renovaro is being referred to more favorably in the media. Company Overall Sentiment Renovaro Neutral Leisure Acquisition Negative Is RENB or LACQ more profitable? Leisure Acquisition's return on equity of 30.17% beat Renovaro's return on equity.Company Net Margins Return on Equity Return on Assets RenovaroN/A -61.84% -48.07% Leisure Acquisition N/A 30.17%6.14% Which has higher valuation and earnings, RENB or LACQ? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRenovaroN/AN/A-$80.65M-$0.77-0.38Leisure AcquisitionN/AN/A$4.31MN/AN/A Which has more volatility & risk, RENB or LACQ? Renovaro has a beta of 0.62, suggesting that its share price is 38% less volatile than the S&P 500. Comparatively, Leisure Acquisition has a beta of -0.3, suggesting that its share price is 130% less volatile than the S&P 500. SummaryRenovaro and Leisure Acquisition tied by winning 4 of the 8 factors compared between the two stocks. Get Leisure Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for LACQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LACQ vs. The Competition Export to ExcelMetricLeisure AcquisitionPharmaceutical Preparations Industry SectorNASDAQ ExchangeMarket Cap$13.91M$6.53B$2.53B$8.39BDividend YieldN/A2.64%13.04%4.10%P/E RatioN/A8.9211.3419.71Price / SalesN/A252.243,509,754.70117.54Price / Cash20.0365.8559.5734.62Price / Book-11.766.463.554.50Net Income$4.31M$143.98M-$428.08M$248.18M Leisure Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LACQLeisure AcquisitionN/A$2.24-7.6%N/A+255.9%$13.91MN/A0.00N/ANegative NewsGap DownHigh Trading VolumeRENBRenovaro0.8116 of 5 stars$0.34+3.7%N/A-69.9%$53.20MN/A-0.3620High Trading VolumeFBIOFortress Biotech1.6417 of 5 stars$1.74+5.5%$21.00+1,106.9%-14.1%$51.45M$57.68M-0.57170VRCAVerrica Pharmaceuticals4.2326 of 5 stars$0.55+8.6%$9.50+1,627.3%-92.7%$50.85M$7.57M-0.3040Analyst RevisionPEPGPepGen3.1313 of 5 stars$1.53+1.3%$9.67+531.8%-89.6%$50.06MN/A-0.5130Gap UpCUECue Biopharma3.8829 of 5 stars$0.77+2.3%$3.00+290.7%-68.1%$47.47M$9.29M-0.8560Gap DownATNMActinium Pharmaceuticals1.2083 of 5 stars$1.52-1.9%$4.00+163.2%N/A$47.42M$81,000.00-1.0930Trending NewsBDRXBiodexa Pharmaceuticals0.8739 of 5 stars$1.29+4.9%N/AN/A$47.14M$83,000.000.0020ONCYOncolytics Biotech1.7187 of 5 stars$0.53-0.8%$4.33+711.5%-62.1%$46.15MN/A-1.9830Analyst ForecastGap DownIMRXImmuneering2.1364 of 5 stars$1.28+7.6%$15.33+1,097.9%-3.9%$46.06M$320,000.00-0.6560STTKShattuck Labs2.5735 of 5 stars$0.96-3.1%$7.50+680.8%-86.1%$46.01M$4.61M-0.63100Gap Up Related Companies and Tools Related Companies RENB Alternatives FBIO Alternatives VRCA Alternatives PEPG Alternatives CUE Alternatives ATNM Alternatives BDRX Alternatives ONCY Alternatives IMRX Alternatives STTK Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LACQ) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredA new financial chapter Porter Stansberry says what happened last week could become the defining legacy of his financial publishing ca...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Leisure Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Leisure Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
